Creekmur Asset Management LLC Gain Therapeutics, Inc. Transaction History
Creekmur Asset Management LLC
- $437 Billion
- Q4 2024
A detailed history of Creekmur Asset Management LLC transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Creekmur Asset Management LLC holds 4,440 shares of GANX stock, worth $9,368. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,440
Previous 4,440
-0.0%
Holding current value
$9,368
Previous $7.9 Million
21.35%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GANX
# of Institutions
30Shares Held
2.69MCall Options Held
5.7KPut Options Held
10.6K-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$1.24 Million0.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$1.19 Million0.06% of portfolio
-
Geode Capital Management, LLC Boston, MA267KShares$564,2580.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA177KShares$373,6280.0% of portfolio
-
Joel Greenblatt Gotham Asset Management, LLC | New York, Ny158KShares$333,7070.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $25.1M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...